Anixa Biosciences to Present at the 18th Annual European Life Sciences CEO Forum

Core Insights - Anixa Biosciences, Inc. will participate in the 18th Annual European Life Sciences CEO Forum to discuss its innovative cancer therapies [1][2][4] - The company is focusing on its CAR-T therapy for ovarian cancer and a breast cancer vaccine, developed in collaboration with leading research institutions [2][4] Company Overview - Anixa is a clinical-stage biotechnology company dedicated to cancer treatment and prevention [4] - The company’s pipeline includes a novel CAR-T therapy for ovarian cancer and vaccines for breast cancer and other hard-to-treat cancers [4] Event Details - The 18th Annual European Life Sciences CEO Forum will take place on February 26-27, 2025, at the Hilton Zurich Airport Hotel [6] - Mike Catelani, President and CFO, will present at the event and engage in one-on-one meetings with potential partners and investors [3][6]